Demetra Ashley spent three decades at the U.S. Drug Enforcement Administration.
As the former acting assistant administrator of the DEA, she told a Senate committee in 2017 about the need for a "robust regulatory program" to stop diversion of opioids and other controlled prescription drugs.
"Ms. Ashley is following in the footsteps of many former federal regulators who take blood money from Purdue after leaving their job. This should not be allowed," said Dr. Andrew Kolodny, the co-director of opioid policy research at Brandeis University. Kolodny has been a paid consultant for plaintiffs suing Purdue Pharma and its owners, the Sacklers.
Get ready, skywatchers. The last supermoon of 2019 will be visible in the night sky tonight, coinciding with the spring equinox that heralds the start of a new season. Here are tips on how to check it out.
"They’re phenomenal businesses if you look at the margins," one venture capitalist said about meditation apps. "It doesn’t cost these mediation companies anything to serve this content. It’s really inexpensive to create and ... these concepts have been around forever."
Thanks for reading the Morning Rundown.
If you have any comments — likes, dislikes — drop me an email at: firstname.lastname@example.org
If you would like to receive the Morning Rundown in your inbox Monday to Friday, please sign-up here.
CLARIFICATION (Oct. 28, 2019, 9:05 p.m. ET): An earlier version of this article should have disclosed that Dr. Andrew Kolodny is a paid consultant for plaintiffs against Purdue and the Sacklers.
Petra Cahill is a senior editor and writer for NBC News Digital. She writes NBC News' Morning Rundown newsletter.